CooperVision has become a Global Patron of the International Agency for the Prevention of Blindness (IAPB). The company becomes part of a select group of leaders including Allergan, Bayer, Novartis and Standard Chartered Bank that supports IAPB at the highest level to help achieve universal access to eye health.
As part of the relationship, CooperVision and IAPB will collaborate to bring greater awareness and action to the growing prevalence and severity of myopia in children worldwide. A seminal 2015 report on the issue from the World Health Organization (WHO) declared that “myopia and high myopia are increasing globally at an alarming rate, with significant increases in the risks for vision impairment from pathologic conditions associated with high myopia.”
“IAPB are excited about the opportunity to partner with CooperVision to create sustainable and lasting change in eye health, including addressing the substantial global increase in myopia,” said [Peter Holland, Chief Executive, IAPB]. “The leadership, insight and innovation of our Patrons regularly unearth new approaches, models and alliances for greater collective and individual impact. By working together, we exponentially increase our abilities to confront and overcome vision impairment issues.”
